Table 1.

Comparison of baseline characteristics and CMV IgG seropositivity between MF/SS and non-MF/SS patients




MF/SS

Non-MF/SS

P
No. patients 53 26  
No. female (%) 27 (51.0) 15 (57.7) .57 
Median age, y 58 47 .27* 
Race, no. (%)    
   White 35 (66.0) 16 (61.5) .69 
   Black Afro-Caribbean 9 (17.0) 5 (19.2) >.999 
   South/southeast Asian 3 (5.7) 2 (7.7) >.999 
   Ethnic origin not known 6 (11.3) 3 (11.5) >.999 
Automated CMV IgG+, no. (%) 32 (60.4) 16 (61.5) .92 
Median automated value (IQR) 117 (2.2-249) 137 (2.5-250) .88* 
Manual CMV IgG+, no. (%)
 
31 (58.4)
 
15 (57.7)
 
.95
 



MF/SS

Non-MF/SS

P
No. patients 53 26  
No. female (%) 27 (51.0) 15 (57.7) .57 
Median age, y 58 47 .27* 
Race, no. (%)    
   White 35 (66.0) 16 (61.5) .69 
   Black Afro-Caribbean 9 (17.0) 5 (19.2) >.999 
   South/southeast Asian 3 (5.7) 2 (7.7) >.999 
   Ethnic origin not known 6 (11.3) 3 (11.5) >.999 
Automated CMV IgG+, no. (%) 32 (60.4) 16 (61.5) .92 
Median automated value (IQR) 117 (2.2-249) 137 (2.5-250) .88* 
Manual CMV IgG+, no. (%)
 
31 (58.4)
 
15 (57.7)
 
.95
 

All P values were not significant.

IQR indicates interquartile range.

*

Unpaired t test. The χ2 or Fisher exact test was used for all other comparisons

Close Modal

or Create an Account

Close Modal
Close Modal